Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H21NO |
Molecular Weight | 255.3547 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCCOC(C1=CC=CC=C1)C2=C(C)C=CC=C2
InChI
InChIKey=PNYKGCPSFKLFKA-UHFFFAOYSA-N
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)17(19-13-12-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3
Molecular Formula | C17H21NO |
Molecular Weight | 255.3547 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://patents.google.com/patent/WO2010099745A1/it
Sources: https://patents.google.com/patent/WO2010099745A1/it
1-[3-(Benzyloxy)phenyl]-N,N-dimethylethanamine is an intermediate compound in the chemical synthesis of a drug Rivastigmine, which is used to treat Alzheimer's and Parkinson's disease.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:27:58 GMT 2023
by
admin
on
Fri Dec 15 18:27:58 GMT 2023
|
Record UNII |
C4A112M10H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
239-338-0
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
m970
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
C81546
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
SUB11142MIG
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110923
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
25315
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
1753
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
15301-93-6
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
TOFENACIN
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
C4A112M10H
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
2692
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
DTXSID50864578
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
C005834
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY | |||
|
100000077748
Created by
admin on Fri Dec 15 18:27:58 GMT 2023 , Edited by admin on Fri Dec 15 18:27:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |